相似文献
1
Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides.
Turk J Haematol. 2017 Dec 1;34(4):378-379. doi: 10.4274/tjh.2017.0234. Epub 2017 Aug 23.
2
Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort study.
J Am Acad Dermatol. 2020 Mar;82(3):736-738. doi: 10.1016/j.jaad.2019.06.037. Epub 2019 Jun 22.
3
Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Arch Dermatol. 2007 Jan;143(1):45-50. doi: 10.1001/archderm.143.1.45.
4
Gender differences in the risk of secondary malignancies in patients with mycosis fungoides and Sézary syndrome.
J Am Acad Dermatol. 2020 Aug;83(2):647-648. doi: 10.1016/j.jaad.2019.11.051. Epub 2019 Dec 3.
5
Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
JAMA Dermatol. 2014 Jul;150(7):709-15. doi: 10.1001/jamadermatol.2013.7747.
6
Risk of secondary cutaneous malignancies in patients with long-standing mycosis fungoides.
J Am Acad Dermatol. 1994 Aug;31(2 Pt 1):295. doi: 10.1016/s0190-9622(08)81987-1.
7
Epidemiology of mycosis fungoides.
Semin Dermatol. 1994 Sep;13(3):154-9.
8
Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: a Danish nationwide, population-based cohort study.
J Am Acad Dermatol. 2014 Sep;71(3):529-35. doi: 10.1016/j.jaad.2014.03.044. Epub 2014 May 14.
9
Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study.
J Cutan Med Surg. 2017 Nov/Dec;21(6):507-512. doi: 10.1177/1203475417716366. Epub 2017 Jun 14.
10
Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
J Am Acad Dermatol. 2009 Aug;61(2):271-5. doi: 10.1016/j.jaad.2009.03.033. Epub 2009 May 28.
引用本文的文献
1
Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study.
Ann Hematol. 2025 Jun 17. doi: 10.1007/s00277-025-06442-7.
2
Mycosis Fungoides and Associated Malignancies in a Dutch Nationwide Retrospective Cohort Study.
Acta Derm Venereol. 2024 Sep 15;104:adv40065. doi: 10.2340/actadv.v104.40065.
3
Evaluation of secondary malignancies in a large series of mycosis fungoides.
An Bras Dermatol. 2024 May-Jun;99(3):370-379. doi: 10.1016/j.abd.2023.06.004. Epub 2024 Jan 22.
4
The incidences of other primary cancers in patients with mycosis fungoides and Sézary syndrome.
Postepy Dermatol Alergol. 2021 Apr;38(2):289-294. doi: 10.5114/ada.2021.106205. Epub 2021 May 22.
本文引用的文献
1
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.
Blood. 2009 May 21;113(21):5064-73. doi: 10.1182/blood-2008-10-184168. Epub 2009 Mar 11.
2
Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease.
Ann Hematol. 2002 Nov;81(11):659-61. doi: 10.1007/s00277-002-0552-6. Epub 2002 Nov 6.
3
Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma.
J Invest Dermatol. 2000 Jul;115(1):62-5. doi: 10.1046/j.1523-1747.2000.00011.x.
4
Secondary malignant neoplasms in 71 patients with Sézary syndrome.
Arch Dermatol. 1999 Nov;135(11):1381-5. doi: 10.1001/archderm.135.11.1381.
5
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
Cancer Res. 1983 Apr;43(4):1891-8.
Zotero 插件